Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Global Plan To End TB 2016-2020 Cherise Scott, Secretariat 2015 Annual Meeting Cape Town, South Africa www.newtbdrugs.org.

Published byChristopher Tate Modified over 9 years ago

Similar presentations

Presentation on theme: "The Global Plan To End TB 2016-2020 Cherise Scott, Secretariat 2015 Annual Meeting Cape Town, South Africa www.newtbdrugs.org."— Presentation transcript:

1 The Global Plan To End TB 2016-2020 Cherise Scott, Secretariat 2015 Annual Meeting Cape Town, South Africa www.newtbdrugs.org

2 The Global Plan 2016-2020 Special committee: Mel Spigelman Barbara Laughon Cherise Scott Myriam Haxaire-Theeuwes (Janssen) Peter Warner (Gates) Christian Lienhardt (WHO) Consultation with Community Representatives Online consultation broader community

3

4 The New Drugs Framework for 2016-2020

5 Total Investment for New Tools

6 6 Introduction of Child-Friendly TB Medicines 1) 8.4 MILLION ADDITIONAL TB CASES 2) 1.4 MILLION ADDITIONAL TB DEATHS 3) 39.8 MILLION DALYS SUFFERED (56.1 million without discounting) 4) US$ 5.3 BILLION IN ADDITIONAL COSTS FOR TB TREATMENTS (US$ 7.5 billion without discounting) 5) US$ 181 BILLION IN LOST PRODUCTIVITY (US$ 318 billion without discounting), valuing each DALY at per-capita GNI. By 2030, a five-year delay in investment for new tools is estimated to result in: Cost of Inaction Source: Stop TB Partnership’s Global Plan 2016-2020

7 THANK YOU Explore. Learn. Join the conversation. www.newtbdrugs.org

Download ppt "The Global Plan To End TB 2016-2020 Cherise Scott, Secretariat 2015 Annual Meeting Cape Town, South Africa www.newtbdrugs.org."

Similar presentations

Our vision is a world free from TB. Our mission is to address the health, social and economic impact of the global TB epidemic amongst vulnerable and.

Our vision is a world free from TB. Our mission is to address the health, social and economic impact of the global TB epidemic amongst vulnerable and.
W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S Tuberculosis Consultant Tuberculosis: Global Canada Saskatchewan.

W. J. Fenton MD, FRCPC, FACP Clinical Professor of Medicine, U of S Tuberculosis Consultant Tuberculosis: Global Canada Saskatchewan.
3 by 5 progress December 2005 Progress on global access to HIV antiretroviral therapy | 12 April 2015 2 |2 | Antiretroviral therapy coverage in low-

"3 by 5" progress December 2005 Progress on global access to HIV antiretroviral therapy | 12 April |2 | Antiretroviral therapy coverage in low-
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,

Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
TB and poverty agenda in WPR WHO/WPRO Stop TB. World Health Organization Percentage of population living below US$1 a day.

TB and poverty agenda in WPR WHO/WPRO Stop TB. World Health Organization Percentage of population living below US$1 a day.
Key Policy Issues: 2013 Pan-African Parliament / UNAIDS Dialogue Pride Chigwedere, MD, PhD Senior Advisor, UNAIDS Liaison Office to the AU.

Key Policy Issues: 2013 Pan-African Parliament / UNAIDS Dialogue Pride Chigwedere, MD, PhD Senior Advisor, UNAIDS Liaison Office to the AU.
David Oyat Abang NAFOPHANU Uganda

David Oyat Abang NAFOPHANU Uganda
Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.

Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.
Global Fund Replenishment October 3, 2013 RESULTS the power to end poverty.

Global Fund Replenishment October 3, 2013 RESULTS the power to end poverty.
CFCS grant recipient: AFRO Global Alliance (AGA), Ghana Project: TB Voice Network Advocacy, Communication and Social Mobilization (ACSM) Subgroup Meeting.

CFCS grant recipient: AFRO Global Alliance (AGA), Ghana Project: TB Voice Network Advocacy, Communication and Social Mobilization (ACSM) Subgroup Meeting.
“The more there are suffering, then the more natural their sufferings appear. Who wants to prevent the fish in the sea from getting wet? Bertolt Brecht.

“The more there are suffering, then the more natural their sufferings appear. Who wants to prevent the fish in the sea from getting wet? Bertolt Brecht.
Global Plan to Stop TB Stop TB Partnership

Global Plan to Stop TB Stop TB Partnership
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Implications for Countries: Critical Issues in Service Delivery and Decision Making Dr. Yogan Pillay Deputy.

Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Implications for Countries: Critical Issues in Service Delivery and Decision Making Dr. Yogan Pillay Deputy.
AMRSP Workshop Oct 08 Peter Elsenaar AMRSP October 22, 2008 Peter Elsenaar, Senior Advisor, Geneva and Samar Abouraad, Advisor, Beirut GRSP is a hosted.

AMRSP Workshop Oct 08 Peter Elsenaar AMRSP October 22, 2008 Peter Elsenaar, Senior Advisor, Geneva and Samar Abouraad, Advisor, Beirut GRSP is a hosted.
Closing Remarks CPTR 2012 WORKSHOP Carol Nawina Nyirenda – Patient Advocate Executive Director Community Initiative for TB, HIV/AIDS & Malaria (CITAM+),

Closing Remarks CPTR 2012 WORKSHOP Carol Nawina Nyirenda – Patient Advocate Executive Director Community Initiative for TB, HIV/AIDS & Malaria (CITAM+),
PUTTING AN END TO TB WHERE ARE THE OPPORTUNITIES AND WHAT ARE THE CHALLENGES? STRATEGY MEETING ON RESOURCE MOBILIZATION FOR THE GLOBAL FUND TO FIGHT AIDS,

PUTTING AN END TO TB WHERE ARE THE OPPORTUNITIES AND WHAT ARE THE CHALLENGES? STRATEGY MEETING ON RESOURCE MOBILIZATION FOR THE GLOBAL FUND TO FIGHT AIDS,
THE FIGHT TO STOP TB WHAT ARE WE FIGHTING? TUBERCULOSIS: THE WORLD’S NO. 1 KILLER AMONG CURABLE, INFECTIOUS DISEASES But there is hope PEOPLE WHO HAVE.

THE FIGHT TO STOP TB WHAT ARE WE FIGHTING? TUBERCULOSIS: THE WORLD’S NO. 1 KILLER AMONG CURABLE, INFECTIOUS DISEASES But there is hope PEOPLE WHO HAVE.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.

DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
T reatment A ction G roup Update on Global TB Research By Claire Wingfield Treatment Action Group Advisory Council for the Elimination of Tuberculosis.

T reatment A ction G roup Update on Global TB Research By Claire Wingfield Treatment Action Group Advisory Council for the Elimination of Tuberculosis.
Partnerships in TB Vaccine Research & Development

Partnerships in TB Vaccine Research & Development

Similar presentations

Ads by Google